Patient support

Date of preparation: September 2024 / EASYH-1112(2)

Patient Support

Patient support

Bufomix Easyhaler<sup>®</sup> (Budesonide/Formoterol) Support Items

Bufomix Easyhaler^® (Budesonide/Formoterol) Support Items

Patient support

Bufomix Easyhaler<sup>®</sup> (Budesonide/Formoterol) Resources

Bufomix Easyhaler^® (Budesonide/Formoterol) Resources

Patient support

How to use Bufomix Easyhaler<sup>®</sup> (Budesonide/Formoterol)

How to use Bufomix Easyhaler^® (Budesonide/Formoterol)

ORIONPHARMA.IE

DATE OF PREPARATION: MAY 2023/EASYH-688(10)

FULL PRESCRIBING INFORMATION AVAILABLE HERE

For more information about Orion and Sustainability click here

Adverse effects should be reported. You can report side effects directly via the Health Products Regulatory Authority (HPRA) website: www.hpra.ie or by email on medsafety@hpra.ie. Adverse effects should also be reported to Orion Pharma via ie.medicalinformation@orionpharma.com

Orion Pharma Ireland Ltd.
C/o Allphar Services, 4045 Kingswood Rd, Citywest Business Pk, D24V06K
Tel: General Enquiries & Customer Care +353 1 428 7777 /
Medical Information +353 1 468 8482 or
Email ie.medicalinformation@orionpharma.com
Date of Preparation: December 2024 / EASYH-638(10)

Patient support

Patient Support

Bufomix Easyhaler® (Budesonide/Formoterol) Support Items

Bufomix Easyhaler® (Budesonide/Formoterol) Resources

How to use Bufomix Easyhaler® (Budesonide/Formoterol)

Bufomix Easyhaler^® (Budesonide/Formoterol) Support Items

Bufomix Easyhaler^® (Budesonide/Formoterol) Resources

How to use Bufomix Easyhaler^® (Budesonide/Formoterol)